Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

5 Résultats
Structure : Identifiant HAL de la structure : 105755

Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study

C. Biron , P. Seksik , M. Nachury , S. Nancey , Y. Bouhnik , et al.
14. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2019, Copenhague, Denmark. ⟨10.1093/ecco-jcc/jjy222.112⟩
Communication dans un congrès hal-03552294v1

The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study

A. Amiot , M. Serrero , L. Peyrin-Biroulet , J. Filippi , B. Pariente , et al.
14. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2019, Copenhague, Denmark. ⟨10.1093/ecco-jcc/jjy222.835⟩
Communication dans un congrès hal-03552293v1

Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

L. Lair-Mehiri , C. Stefanescu , T. Vaysse , D. Laharie , X. Roblin , et al.
Journal of Crohn's and Colitis, 2019, 13 (1), pp.S478-S479. ⟨10.1093/ecco-jcc/jjy222.839⟩
Article dans une revue hal-03552302v1

Efficacy of ustekinumab in perianal Crohn's disease: the BioLAP multi-centre observational study

C. Biron , P. Seksik , M. Nachury , Y. Bouhnik , A. Amiot , et al.
14. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2019, Copenhague, Denmark. ⟨10.1093/ecco-jcc/jjy222.108⟩
Communication dans un congrès hal-03552295v1

Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience

Pauline Wils , Yoram Bouhnik , Pierre Michetti , Bernard Flourie , Hédia Brixi , et al.
12. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2017, Barcelone, Spain
Communication dans un congrès hal-03553341v1